154 related articles for article (PubMed ID: 30641955)
1. Mouse Models Reveal Role of T-Cytotoxic and T-Reg Cells in Immune Response to Influenza: Implications for Vaccine Design.
Sell S; McKinstry KK; Strutt TM
Viruses; 2019 Jan; 11(1):. PubMed ID: 30641955
[TBL] [Abstract][Full Text] [Related]
2. Intraepithelial T-cell cytotoxicity, induced bronchus-associated lymphoid tissue, and proliferation of pneumocytes in experimental mouse models of influenza.
Sell S; Guest I; McKinstry KK; Strutt TM; Kohlmeier JE; Brincks E; Tighe M; Blackman MA; Woodland DL; Dutton RW; Swain SL
Viral Immunol; 2014 Dec; 27(10):484-96. PubMed ID: 25479178
[TBL] [Abstract][Full Text] [Related]
3. Inducible bronchus-associated lymphoid tissue (iBALT) synergizes with local lymph nodes during antiviral CD4+ T cell responses.
Richert LE; Harmsen AL; Rynda-Apple A; Wiley JA; Servid AE; Douglas T; Harmsen AG
Lymphat Res Biol; 2013 Dec; 11(4):196-202. PubMed ID: 24364842
[TBL] [Abstract][Full Text] [Related]
4. Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells.
Pizzolla A; Wang Z; Groom JR; Kedzierska K; Brooks AG; Reading PC; Wakim LM
Proc Natl Acad Sci U S A; 2017 May; 114(20):5225-5230. PubMed ID: 28461487
[TBL] [Abstract][Full Text] [Related]
5. Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.
Gasper DJ; Neldner B; Plisch EH; Rustom H; Carrow E; Imai H; Kawaoka Y; Suresh M
PLoS Pathog; 2016 Dec; 12(12):e1006064. PubMed ID: 27997610
[TBL] [Abstract][Full Text] [Related]
6. Inducible Bronchus-Associated Lymphoid Tissues (iBALT) Serve as Sites of B Cell Selection and Maturation Following Influenza Infection in Mice.
Tan HX; Esterbauer R; Vanderven HA; Juno JA; Kent SJ; Wheatley AK
Front Immunol; 2019; 10():611. PubMed ID: 30984186
[TBL] [Abstract][Full Text] [Related]
7. Induction of lung CD8
Moriyama M; Takeyama H; Hasegawa H; Ichinohe T
Vaccine; 2017 Dec; 35(48 Pt B):6620-6626. PubMed ID: 29079103
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge.
Epstein SL; Stack A; Misplon JA; Lo CY; Mostowski H; Bennink J; Subbarao K
Int Immunol; 2000 Jan; 12(1):91-101. PubMed ID: 10607754
[TBL] [Abstract][Full Text] [Related]
9. CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus.
Lee YT; Ko EJ; Lee Y; Lee YN; Bian Z; Liu Y; Kang SM
J Virol; 2016 Aug; 90(15):6746-6758. PubMed ID: 27194758
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of CD4+Foxp3+ T-regulatory cells on the B and T helper cell responses to influenza virus vaccination.
Surls J; Nazarov-Stoica C; Kehl M; Casares S; Brumeanu TD
Vaccine; 2010 Oct; 28(45):7319-30. PubMed ID: 20832492
[TBL] [Abstract][Full Text] [Related]
11. Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines.
Dong W; Bhide Y; Sicca F; Meijerhof T; Guilfoyle K; Engelhardt OG; Boon L; de Haan CAM; Carnell G; Temperton N; de Vries-Idema J; Kelvin D; Huckriede A
Front Immunol; 2018; 9():2312. PubMed ID: 30356772
[TBL] [Abstract][Full Text] [Related]
12. Blockage of regulatory T cells augments induction of protective immune responses by influenza virus-like particles in aged mice.
Wen Z; Wang X; Dong K; Zhang H; Bu Z; Ye L; Yang C
Microbes Infect; 2017 Dec; 19(12):626-634. PubMed ID: 28899815
[TBL] [Abstract][Full Text] [Related]
13. Exogenous Interleukin-33 Contributes to Protective Immunity via Cytotoxic T-Cell Priming against Mucosal Influenza Viral Infection.
Kim CW; Yoo HJ; Park JH; Oh JE; Lee HK
Viruses; 2019 Sep; 11(9):. PubMed ID: 31509992
[TBL] [Abstract][Full Text] [Related]
14. Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.
Nguyen HH; van Ginkel FW; Vu HL; Novak MJ; McGhee JR; Mestecky J
J Virol; 2000 Jun; 74(12):5495-501. PubMed ID: 10823854
[TBL] [Abstract][Full Text] [Related]
15. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
[TBL] [Abstract][Full Text] [Related]
16. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity.
Moyron-Quiroz JE; Rangel-Moreno J; Kusser K; Hartson L; Sprague F; Goodrich S; Woodland DL; Lund FE; Randall TD
Nat Med; 2004 Sep; 10(9):927-34. PubMed ID: 15311275
[TBL] [Abstract][Full Text] [Related]
17. Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells.
Stevenson PG; Hawke S; Bangham CR
J Immunol; 1996 Oct; 157(7):3065-73. PubMed ID: 8816416
[TBL] [Abstract][Full Text] [Related]
18. Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus.
Fossum E; Grødeland G; Terhorst D; Tveita AA; Vikse E; Mjaaland S; Henri S; Malissen B; Bogen B
Eur J Immunol; 2015 Feb; 45(2):624-35. PubMed ID: 25410055
[TBL] [Abstract][Full Text] [Related]
19. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
Kamlangdee A; Kingstad-Bakke B; Osorio JE
J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
[TBL] [Abstract][Full Text] [Related]
20. Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response.
Harling-McNabb L; Deliyannis G; Jackson DC; Gerondakis S; Grigoriadis G; Brown LE
Int Immunol; 1999 Sep; 11(9):1431-9. PubMed ID: 10464164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
